BlackRock Institutional Trust’s Tvardi Therapeutics TVRD Stock Holding History

BlackRock Institutional Trust’s Portfolio TVRD Stock Details TVRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$7.01M	Buy	20,958 +5,647	+37%	+$1.81M	﹤0.01%	2599
2016 Q3	$4.6M	Buy	15,311 +3,734	+32%	+$809K	﹤0.01%	2727
2016 Q2	$2M	Buy	11,577 +18	+0.2%	+$3.92K	﹤0.01%	3038
2016 Q1	$2.59M	Sell	11,559 -142	-1%	-$42.4K	﹤0.01%	2936
2015 Q4	$7.1M	Buy	11,701 +1,528	+15%	+$839K	﹤0.01%	2532
2015 Q3	$5.23M	Buy	10,173 +7,296	+254%	+$4.88M	﹤0.01%	2692
2015 Q2	$1.26M	Buy	2,877 +1,659	+136%	+$641K	﹤0.01%	3285
2015 Q1	$441K	Buy	1,218 +1	+0.1%	+$378	﹤0.01%	3531
2014 Q4	$437K	Sell	1,217 -26	-2%	-$8.37K	﹤0.01%	3521
2014 Q3	$376K	Sell	1,243 -132	-10%	-$54.2K	﹤0.01%	3536
2014 Q2	$843K	Sell	1,375 -30	-2%	-$16.2K	﹤0.01%	3481
2014 Q1	$941K	Buy	+1,405	New	+$831K	﹤0.01%	3430

Other funds holding TVRD

RCP

Rho Capital Partners New York $20.4M AUM

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

EAM

EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock Institutional Trust's TVRD Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Tvardi Therapeutics (TVRD) stake by 37% in Q4 2016, buying an estimated $1.81M and bringing the position to 20,958 shares worth $7.01M. The position accounts for ﹤0.01% of the portfolio, ranked #2599.

BlackRock Institutional Trust first reported a position in TVRD in Q1 2014 and has held it in 12 quarters since. The position peaked at $7.1M in Q4 2015. 101 funds tracked by Wall St. Rank hold TVRD as of Q4 2016.

BlackRock Institutional Trust held 20,958 shares of Tvardi Therapeutics worth $7.01M as of Q4 2016.
BlackRock Institutional Trust bought 5,647 Tvardi Therapeutics shares in Q4 2016, an estimated $1.81M.
Tvardi Therapeutics made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2599 holding.
BlackRock Institutional Trust first reported a position in Tvardi Therapeutics in Q1 2014 and has held it in 12 quarters since.
BlackRock Institutional Trust's Tvardi Therapeutics position peaked at $7.1M in Q4 2015.
101 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.